Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Die Folgen des Klimwandels haben einen direkten Einfluss auf die Primärversorgung in Deutschland: Hitzeschutz insbesondere bei älteren Patienten, die Zunahme von Infektionen und die Verlängerung der Allergiesesaison spielen medizinisch eine bedeutsame Rolle. Aber auch in der Prävention und der Aufklärung der Patienten kommt den Hausärztinnen und -ärzten eine besondere Rolle zu. Direkt aus der Praxis berichtet im Live-Webinar am 13. Mai von 18 bis 19 Uhr unser Experte Dr. med. Robin Maitra.
Erweiterte Suche
Anmelden
nach oben
Current Treatment Options in Gastroenterology
Erschienen in: Current Treatment Options in Gastroenterology 4/2019

09.11.2019 | Gastroenterology for Geriatric Patients (S Katz and A Afzali, Section Editors)

Pancreatic Cysts in the Elderly

verfasst von: Luis F. Lara, MD, Anjuli Luthra, MD, Darwin L. Conwell, MD, MS, Somashekar G. Krishna, MD, MPH

Erschienen in: Current Treatment Options in Gastroenterology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of review

Incidental pancreatic cysts are common, and management strategies continue to evolve. This review summarizes diagnostic and management recommendations in older patients with these lesions based on guidelines and best clinical evidence.

Recent findings

Diagnosis of cyst type has been enhanced with improved imaging and cyst fluid analysis and visualization. Recent outcome studies indicate that certain cyst types should be followed independent of patient age as long as certain criteria which are reviewed are met.

Summary

Differentiation of pancreatic cyst type is important as this dictates the need for long-term follow-up. Because most cyst-related neoplasia occurs in older patients, surveillance should continue within certain guidelines.
Literatur
1.
•• Tanaka M, Fernandez-el Castillo C, Kamisawa T, et al. Revisions of the international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17:738–53 Recent updated multidisciplinary guidelines on IPMN surveillance.
2.
Zhang XM, Mitchell DG, Dohke M, et al. Pancreatic cysts: depiction on single-shot fast spin-echo MR Images. Radiology. 2002;223:547–53.PubMed
3.
Laffan TA, Horton KM, Klein AP, et al. Prevalence of unsuspected pancreatic cysts on MDCT. Am J Roentgenol. 2008;191:802–7.
4.
Brugge WR. Approach to cystic pancreatic lesions. Gastrointest Endosc Clin N Am. 2005;15:485–96.PubMed
5.
Kimura W, Nagai H, Kuroda A, et al. Analysis of small cystic lesions of the pancreas. Int J Pancreatol. 1995;18:197–206.PubMed
6.
•• European evidence-based guidelines on pancreatic cystic neoplasms. The European Study Group on Cystic Tumours of the Pancreas. Gut. 2018;67:789–804 Most recently updated guidelines on all type of pancreatic cyst management.
7.
Vege SS, Ziring B, Jain R, et al. American Gastroenterological Association Institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148:819–22.PubMed
8.
Estrella JS, Li L, Rashid A, et al. Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution. Am J Surg Pathol. 2014;38:147–57.PubMed
9.
Law JK, Ahmed A, Singh VK, et al. A systematic review of solid-pseudopapillary neoplasms: are these rare lesions? Pancreas. 2014;43:331–7.PubMedPubMedCentral
10.
Kimura W, Moriya T, Hirai I, et al. Multicenter study of serous cystic neoplasm of the Japan pancreas society. Pancreas. 2012;41:380–7.PubMed
11.
Lee LS, Clancy T, Kadiyala V, et al. Interdisciplinary management of cystic neoplasms of the pancreas. Gastroenterol Res Pract. 2012;2012:513163.PubMedPubMedCentral
12.
Tanaka M, Fernandez-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–97.PubMed
13.
Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg. 2007;246:644–51.PubMed
14.
Waters JA, Schmidt CM, Pinchot JW, et al. CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg. 2008;12:101–9.PubMed
15.
Reid-Lombardo KM, St. Sauver J, Li Z, et al. Incidence, prevalence, and management of intraductal papillary mucinous neoplasm in Olmsted County, Minnesota, 1984-2005: a population study. Pancreas. 2008;37:139–44.PubMedPubMedCentral
16.
Sahora K, Mino-Kenudson M, Brugge W, et al. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg. 2013;258(3):466–75.PubMed
17.
• Goh BK, Tan DM, Thng CH, et al. Are the Sendai and Fukuoka consensus guidelines for cystic mucinous neoplasms of the pancreas useful in the initial triage of all suspected pancreatic cystic neoplasms? A single-institution experience with 317 surgically-treated patients. Ann Surg Oncol. 2014;21:1919–26 A comparison trial of the effectiveness of the proposed guidelines in patients who ultimately had surgery.PubMed
18.
Fritz S, Klauss M, Bergmann F, et al. Pancreatic main-duct involvement in branch-duct IPMNs. Ann Surg. 2014;260:848–56.PubMed
19.
• Elta GH, Enestvedt BK, Sauer BG, et al. ACG Clinical Guideline: diagnosis and management of pancreatic cysts. Am J Gastroenterol. 2018;113:464–79 A clinically appropriate guideline for all pancreatic cysts.
20.
Megibow AJ, Baker ME, Morgan DE, et al. Management of incidental pancreatic cysts: a white paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2017;14:911–23.PubMed
21.
•• Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32 First proposed guidelines for cystic mucinous lesions of the pancreas.PubMed
22.
Pelaez-Luna M, Chari ST, Smyrk TC, et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol. 2007;102:1759–64.PubMed
23.
Tang RS, Weinberg B, Dawson DW, et al. Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol. 2008;6:815–9.PubMed
24.
Kaimakliotis P, Riff B, Pourmand K, et al. Sendai and Fukuoka consensus guidelines identify advanced neoplasia in patients with suspected mucinous cystic neoplasms of the pancreas. Clin Gastroenterol Hepatol. 2015;13:1808–15.PubMed
25.
Ma GK, Goldberg DS, Thiruvengadam N, et al. Comparing American Gastroenterological Association pancreatic cyst management guidelines with Fukuoka consensus guidelines as predictors of advanced neoplasia in patients with suspected pancreatic cystic neoplasms. J Am Coll Surg. 2016;223:729–37.PubMed
26.
•• Singhi AD, Zeh HJ, Brand RE, et al. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathological study of 225 patients with supporting molecular data. Gastrointest Endosc. 2016;83:1107–17 A major study indicating the poor ability of the AGA guidelines in identifying high risk lesions.
27.
Kwong WT, Hunt GC, Fehmi SM, et al. Low rates of malignancy and mortality in asymptomatic patients with suspected neoplastic pancreatic cysts beyond 5 years of surveillance. Clin Gastroenterol Hepatol. 2016;14:865–71.PubMed
28.
Watanabe Y, Endo S, Nishihara K, et al. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines. Surg Today. 2018;48:1011–9.PubMed
29.
Pérez-Cuadrado-Robles E, Uribarri-González L, Borbath I, et al. Risk of advanced lesions in patients with branch-duct IPMN and relative indications for surgery according to European evidence-based guidelines. Dig Liver Dis. 2019;51:882–6.PubMed
30.
Nguyen AH, Toste PA, Farrell JJ. Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer. J Gastrointest Surg. 2015;19:258–65.PubMed
31.
Oh HC, Brugge WR. EUS-guided pancreatic cyst ablation: a critical review (with video). Gastrointest Endosc. 2013;77:526–33.PubMed
32.
Khalid A, Brugge W. ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Am J Gastroenterol. 2007;102:2339–49.PubMed
33.
Maker AV, Lee LS, Raut CP, et al. Cytology from pancreatic cysts has marginal utility in surgical decision-making. Ann Surg Oncol. 2008;15:3187–92.PubMed
34.
Singhi AD, Nikiforova MN, McGrath K. DNA testing of pancreatic cystic fluid: is it ready for prime time? Lancet Gastroenterol Hepatol. 2017;2:63–72.PubMed
35.
• Wu J, Matthaei H, Maitra A, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011;3:92ra66 First study to report DNA mutation analysis and correlation with outcomes.PubMedPubMedCentral
36.
Sreenarasimhaiah J, Lara LF, Jazrawi SF, et al. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts. JOP. 2009;10:163–8.PubMed
37.
Jones M, Zheng Z, Wang J, et al. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts. Gastrointest Endosc. 2016;83:140–8.PubMed
38.
Garcia-Carracedo D, Chen ZM, Qiu W, et al. PIK3CA mutations in mucinous cystic neoplasms of the pancreas. Pancreas. 2014;43:245–9.PubMedPubMedCentral
39.
Khalid A, Zahid M, Finkelstein SD, et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a rare report of the PANDA study. Gastrointest Endosc. 2009;69:1095–102.PubMed
40.
• Das A, Brugge W, Mishra G, et al. Managing incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategy. Endosc Int Open. 2015;3:E479–86 A large surgical case series showing the benefits of confocal laser endomicroscopy for the evaluation of pancreatic cysts.PubMedPubMedCentral
41.
Krishna SG, Hart PA, Malli A, et al. Endoscopic ultrasound-guided confocal laser endomicroscopy increases accuracy of differentiation of pancreatic cystic lesions. Clin Gastroenterol Hepatol. 2019.
42.
Maguchi H, Tanno S, Mizuno N, et al. Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan. Pancreas. 2011;40:364–70.PubMed
43.
• LaFemina J, Katabi N, Klimstra D, et al. Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. Ann Surg Oncol. 2013;20:440–7 A study indicating that cyst growth rate is associated with malignant transformation.PubMed
44.
Kolb JM, Argiriadi P, Lee K, et al. Higher growth rate of branch duct intraductal papillary mucinous neoplasms associates with worrisome features. Clin Gastroenterol Hepatol. 2018;16:1481–7.PubMed
45.
Akahoshi K, Ono H, Akasu M, et al. Rapid growth speed of cysts can predict malignant intraductal mucinous papillary neoplasms. J Surg Res. 2018;231:195–200.PubMed
46.
Mukewar SS, Sharma A, Phillip N, et al. Risk of pancreatic cancer in patients with pancreatic cysts and family history of pancreatic cancer. Clin Gastroenterol Hepatol. 2018;16:1123–30.PubMed
47.
Mandai K, Uno K, Yasuda K. Does a family history of pancreatic ductal adenocarcinoma and cyst size influence the follow-up strategy for intraductal papillary mucinous neoplasms of the pancreas? Pancreas. 2014;43:917–21.PubMed
48.
Das A, Ngamruengphong S, Nagendra S, et al. Asymptomatic pancreatic cystic neoplasm: a cost-effectiveness analysis of different strategies of management. Gastrointest Endosc. 2009;70:690–9.PubMed
49.
Kwok K, Chang J, Duan L, et al. Competing risks for mortality in patients with asymptomatic pancreatic cystic neoplasms: implications for clinical management. Am J Gastroenterol. 2017;112:1330–6.PubMed
50.
Gaujoux S, Brennan MF, Gonen M, et al. Cystic lesions of the pancreas: changes in the presentation and management of 1424 patients at a single institution over a 15-year time period. J Am Coll Surg. 2011;212:590–600.PubMed
51.
Spinelli K, Fromwiller T, Daniel R, et al. Cystic pancreatic neoplasms: observe or operate. Ann Surg. 2004;239:651–9.PubMedPubMedCentral
52.
Bellin MD, Gelrud A, Arreaza-Rubin G, et al. Total pancreatectomy with islet autotransplantation: summary of an NIDDK workshop. Ann Surg. 2015;261:21–9.PubMedPubMedCentral
53.
Lara LF, Takita M, Burdick JS, et al. A study of the clinical impact of a 20-minute secretin-stimulated endoscopic pancreas function test and performance according to clinical variables. Gastrointest Endosc. 2017;86:1048–55.PubMed
54.
Scheiman JM, Hwang JH, Moayeddi P. American Gastroenterological Association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148:824–48.PubMed
55.
Roch AM, DeWitt JM, Al-Haddad MA, et al. Non operative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients. J Am Coll Surg. 2014;219:122–9.PubMed
Metadaten
Titel
Pancreatic Cysts in the Elderly
verfasst von
Luis F. Lara, MD
Anjuli Luthra, MD
Darwin L. Conwell, MD, MS
Somashekar G. Krishna, MD, MPH
Publikationsdatum
09.11.2019
Verlag
Springer US
Erschienen in
Current Treatment Options in Gastroenterology / Ausgabe 4/2019
Print ISSN: 1092-8472
Elektronische ISSN: 1534-309X
DOI
https://doi.org/10.1007/s11938-019-00260-3

Weitere Artikel der Ausgabe 4/2019

Current Treatment Options in Gastroenterology 4/2019 Zur Ausgabe

Gastroenterology for Geriatric Patients (S Katz and A Afzali, Section Editors)

Sleep Disturbances in the Elderly Patient with Inflammatory Bowel Disease

Inflammatory Bowel Disease (G Lichtenstein, Section Editor)

The Evolving Role of Thiopurines in Inflammatory Bowel Disease

Gastroenterology for Geriatric Patients (S Katz and A Afzali, Section Editors)

Treatment of Severe and Fulminnant Clostridioides difficile Infection

Genetics in Gastroenterology Practice (B Katona, Section Editor)

Hereditary or Not? Understanding Serrated Polyposis Syndrome

Stomach (P Malfertheiner, Section Editor)

Initiatives for a Healthy Stomach

Gastroenterology for Geriatric Patients (S Katz and A Afzali, Section Editors)

Immune-Mediated Colitis

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise